Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2024-02-14 5:01 pm Sale |
2023-12-31 | 13G | Gracell Biotechnologies Inc. GRCL |
RA Capital Management, L.P. | 48,600,221 9.990% |
-79![]() (-0.00%) |
Filing History |
2024-02-14 08:20 am Sale |
2023-12-31 | 13G | Gracell Biotechnologies Inc. GRCL |
William Cao Wei | 77,141,530 15.900% |
-18,004,855![]() (-18.92%) |
Filing History |
2024-02-14 08:00 am Purchase |
2023-12-31 | 13G | Gracell Biotechnologies Inc. GRCL |
Sio Capital Management, LLC | 25,007,900 5.200% |
25,007,900![]() (New Position) |
Filing History |
2024-02-13 5:26 pm Unchanged |
2023-12-31 | 13G | Gracell Biotechnologies Inc. GRCL |
LAV Biosciences Fund V L.P. | 25,406,680 5.300% |
0 (Unchanged) |
Filing History |
2024-02-13 5:00 pm Unchanged |
2023-12-31 | 13G | Gracell Biotechnologies Inc. GRCL |
Vivo Opportunity Fund Holdings, L.P. | 38,152,030 7.700% |
0 (Unchanged) |
Filing History |
2023-10-19 08:10 am Sale |
2023-10-17 | 13G | Gracell Biotechnologies Inc. GRCL |
TEMASEK HOLDINGS LTD | 47,944,317 9.990% |
-1,565,385![]() (-3.16%) |
Filing History |
2023-08-21 4:30 pm Purchase |
2023-08-10 | 13G | Gracell Biotechnologies Inc. GRCL |
RA Capital Management, L.P. | 48,600,300 9.990% |
48,600,300![]() (New Position) |
Filing History |
2023-08-18 4:56 pm Purchase |
2023-08-10 | 13G | Gracell Biotechnologies Inc. GRCL |
Vivo Opportunity Fund Holdings, L.P. | 38,152,030 7.800% |
38,152,030![]() (New Position) |
Filing History |
2023-08-11 4:23 pm Purchase |
2023-08-10 | 13D | Gracell Biotechnologies Inc. GRCL |
ORBIMED ADVISORS LLC | 7,641,531 8.000% |
57,955![]() (+0.76%) |
Filing History |
2023-03-31 4:48 pm Purchase |
2023-03-29 | 13D | Gracell Biotechnologies Inc. GRCL |
ORBIMED ADVISORS LLC | 7,583,576 11.200% |
1,612,904![]() (+27.01%) |
Filing History |
2023-03-08 2:01 pm Purchase |
2023-02-28 | 13G | Doximity, Inc. DOCS |
BLACKROCK INC BLK |
5,381,384 4.500% |
5,381,384![]() (New Position) |
Filing History |
2023-02-14 4:20 pm Unchanged |
2022-12-31 | 13G | Gracell Biotechnologies Inc. GRCL |
ORBIMED ADVISORS LLC | 5,970,672 8.800% |
0 (Unchanged) |
Filing History |
2023-02-14 12:03 pm Sale |
2022-12-31 | 13G | Gracell Biotechnologies Inc. GRCL |
Frazier Life Sciences Public Fund, L.P. | 0 0.000% |
-17,104,865![]() (Position Closed) |
Filing History |
2023-02-13 3:54 pm Sale |
2023-02-14 | 13G | Gracell Biotechnologies Inc. GRCL |
Capital International Investors | 16,200,000 4.800% |
-4,118,820![]() (-20.27%) |
Filing History |
2023-02-07 4:00 pm Purchase |
2022-12-31 | 13G | Gracell Biotechnologies Inc. GRCL |
William Cao Wei | 95,146,385 26.900% |
1,914,845![]() (+2.05%) |
Filing History |
2023-02-06 2:36 pm Sale |
2022-12-30 | 13G | Gracell Biotechnologies Inc. GRCL |
WELLINGTON MANAGEMENT CO LLP | 0 0.000% |
-21,460,705![]() (Position Closed) |
Filing History |
2023-02-03 12:10 pm Purchase |
2022-12-31 | 13G | Gracell Biotechnologies Inc. GRCL |
BLACKROCK INC BLK |
4,887,820 7.200% |
4,887,820![]() (New Position) |
Filing History |
2022-03-17 12:42 pm Purchase |
2022-03-10 | 13G | Gracell Biotechnologies Inc. GRCL |
Frazier Life Sciences Public Fund, L.P. | 17,104,865 5.100% |
17,104,865![]() (New Position) |
Filing History |
2022-02-14 2:53 pm Purchase |
2021-12-31 | 13G | Gracell Biotechnologies Inc. GRCL |
William Cao Wei | 93,231,540 26.900% |
93,231,540![]() (New Position) |
Filing History |
2022-02-11 4:23 pm Sale |
2021-12-31 | 13G | Gracell Biotechnologies Inc. GRCL |
ORBIMED ADVISORS LLC | 5,970,672 8.900% |
-23,882,692![]() (-80.00%) |
Filing History |